Format

Send to

Choose Destination
Fundam Clin Pharmacol. 2015 Feb;29(1):10-20. doi: 10.1111/fcp.12091. Epub 2014 Sep 25.

Pharmacology and mechanisms of action of new oral anticoagulants.

Author information

1
Department of Pharmacology and UMR ICAN 1166, Faculty of Medicine, Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Universités, UPMC Univ Paris 06, F-75013, Paris, France; Department of Pharmacology and CIC-1421, Institute of Cardiometabolism and Nutrition (ICAN), AP-HP, Pitié-Salpêtrière Hospital, F-75013, Paris, France; INSERM, Institute of Cardiometabolism and Nutrition (ICAN), CIC-1421 and UMR ICAN 1166, F-75013, Paris, France.

Abstract

The new oral anticoagulants are announced as an important therapeutic revolution, particularly after their approval by authorities for stroke prevention in atrial fibrillation. However, the pharmacology of these new drugs is not homogeneous. In this review, we summarize the main pharmacological characteristics of the new direct anti-Xa and anti-IIa agents.

KEYWORDS:

anticoagulant; apixaban; dabigatran; edoxaban; heparin; pharmacology; rivaroxaban

PMID:
25196680
DOI:
10.1111/fcp.12091
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center